Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Hydroxychloroquine: CIA employees warned against potentially fatal side effects of Trump’s favoured coronavirus drug

‘Please do not obtain this medication on your own,’ workforce website response warns

Louise Hall
Tuesday 14 April 2020 11:20 EDT
Comments
Dr Anthony Fauci advises against prescribing malaria drug to treat coronavirus

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

CIA employees have been warned that Donald Trump’s favoured anti-malaria coronavirus treatment drug could potentially have life-threatening side effects, including sudden death, according to a report by The Washington Post.

Mr Trump has frequently recommended the use of hydroxychloroquine, a drug which is used in the treatment of malaria, in attempting to combat Covid-19 during his press briefings on a number of occasions.

However, in late March, the CIA workforce were warned against the drug on a website for CIA employees with questions related to the spread of coronavirus, according to The Post.

“At this point, the drug is not recommended to be used by patients except by medical professionals prescribing it as part of ongoing investigational studies,” the advice read, according to the report.

“There are potentially significant side effects, including sudden cardiac death, associated with hydroxychloroquine and its individual use in patients need to be carefully selected and monitored by a health care professional.”

The memo, which was posted in response to an employee’s enquiry as to whether they should take the drug without a prescription finished in bold type: “Please do not obtain this medication on your own”, the newspaper said.

The CIA declined to comment on internal workforce communications when contacted by The Post.

Trump’s endorsement of the proposal to use the anti-malaria drug has proved highly controversial over the last month.

In late March Mr Trump hailed the combination of hydroxychloroquine with an antibiotic known as azithromycin as a possible “way out” for the US against coronavirus.

The number of cases in the US of the disease surpassed 580,000 as of Tuesday. The country now has the most confirmed cases of the disease in the world.

“I want them to try it, and it may work and it may not work. But if it doesn’t work, there is nothing lost by doing it,” the president said earlier this month. “What do you have to lose?”

However, medical experts continue to insist there is no concrete scientific evidence of the drug’s effectiveness or safety when used against coronavirus.

“The evidence that you’re talking about … is anecdotal evidence”, said Dr Anthony Fauci, the nation’s top diseases expert, in March, when asked if it was considered a treatment for Covid-19.

The basis for the belief in the drug comes from a small initial study in France which has been treated with scepticism.

“There could be deaths. This is a new virus, and so we should not be promoting any medication or drug for any disease that has not been proven and approved by the FDA,” American Medical Association president Dr Patrice Harris said in an interview with CNN.

Results from trials of the drug by the US Food and Drug Administration will not conclude for at least a month.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in